Small Cell Lung Cancer | Hope With Answers℠

Small cell lung cancer (SCLC) is a much less common form of lung cancer, affecting roughly 1 in every 10 people diagnosed with lung cancer. Small cell lung cancer is particularly aggressive. It often returns after initial rounds of chemotherapy.

Because of the Recalcitrant Cancer Research Act, the National Cancer Institute (NCI), in partnership with the lung cancer research community, is making SCLC a major focus of research, resulting in a greater number of clinical trials in the pipeline.

Small Cell Lung Cancer | Hope With Answers℠

Understand the basics of small cell lung cancer in this intro video from Hope With Answers℠. This series provides information for those newly diagnosed with lung cancer. In the intro video, patient advocate Jill Feldman discusses small cell lung cancer with lung cancer researcher Dr. Christine Lovly of Vanderbilt University.

In the intermediate video, Jill and Dr. Lovly provide more details for those who need a deeper knowledge about issues surrounding lung cancer.

The in-depth Hope With Answers℠ video provides the next level of information for patients to understand treatment options, particularly if they’ve experienced resistance or if their lung cancer has progressed. Learn more through this conversation between Dr. Christine Lovly and patient advocates Jill Feldman and Montessa Lee.


New approved treatment for SCLC

Often diagnosed at an advanced stage, SCLC has historically offered limited treatment options. Learn more about this latest approved treatment.

Living with lung cancer

"I made it my mission to live."

Montessa, a vegetarian, never smoker and special education teacher is living with lung cancer.

Get informed.Stay informed.

Join our community.

Sign up to get more resources on the latest in lung cancer research.